umdnj logo

Table Of Contents

Medical Update:
Treatment of TB:
Managing Adverse Drug Effects

Tuesday, August 30, 2011
1:00 pm - 2:30 pm, EST

Sponsored By
New Jersey Medical School Global Tuberculosis Institute,
University of Medicine & Dentistry of New Jersey (UMDNJ)

This activity is supported by an educational grant from the Centers for Disease Control and Prevention, Division of Tuberculosis Elimination

The New Jersey Medical School Global Tuberculosis Institute is the Tuberculosis Regional Training and Medical Consultation Center for the Northeastern United States

Course Description and Overall Goal
This web-based seminar will specifically cover managing medication side effects in TB patients in order to decrease the risk of toxicity and ensure completion of therapy. The presentation will include information on drug-specific toxicities, recommendations for management of side effects, and resources for providers. A case presentation will be included along with time for discussion.

Who Should Attend
This web-based seminar is designed for physicians and other health care providers who manage TB patients.

Why Course Is Needed
Treatment of tuberculosis requires multi-drug combination therapy over a sufficient time period and all anti-TB medications are associated with a predictable incidence of adverse effects ranging from mild to severe. Mild adverse effects can generally be managed symptomatically, where as more severe effects may cause significant morbidity and complicate treatment. Close monitoring of patients is crucial to ensure appropriate management of adverse effects during anti-TB therapy, including patient education, clinical examination and laboratory testing. Major adverse drug reactions may be best managed in consultation with experienced clinicians.


Upon completion of this activity participants will be able to:

  • Recognize the common side effects associated with anti-TB medications in order to provide patient education and promote adherence.
  • Describe the importance of monitoring patients for adverse drug reactions during TB therapy to prevent treatment complications.
  • Discuss approaches for managing adverse drug effects of TB drugs to minimize toxicity and ensure treatment completion.

Course Requirements
  • Access to high speed internet
  • Computer with speakers for listening to audio
  • Telephone connection (required for verbal participation during Q & A session)

Tuesday, August 30, 2011

1:00 pm        Welcome and Overview – Dr. Lardizabal, MD
1:05 pm        Managing Adverse Drug Reactions – Robert Belknap, MD

1:50 pm        Interactive Case Discussion – Henry Fraimow, MD

2:15 pm        Questions and Discussion

2:30 pm        Adjourn


Continuing Education Information

Continuing education credits are not provided for this activity.

Disclosure Policy

Registration Information and Fee

Registration priority will be given to individuals within the Northeastern Region, including Connecticut, Delaware, District of Columbia, Indiana, Maine, Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, Vermont and West Virginia, and the cities of Baltimore, Detroit, New York City and Philadelphia.

There is no limit to the number of participants at one location viewing from one room and computer. However, each site must identify a contact person to receive conference information, submit the sign-in sheet, and share the link to the online conference evaluation after the seminar.

Notification of acceptance and additional information will be sent via email. Please be sure to provide a valid email address on the registration form.

This activity is free of charge. However, if you register and are unable to participate, we would appreciate you informing us so that we may accommodate others.

Please register online at:


NJMS Global TB Institute
Newark, NJ

  • Alfred Lardizabal, MD
    Associate Director

University of Colorado
Denver, CO

  • Robert Belknap, MD
    Assistant Professor of Medicine in the Division of Infectious Diseases

Cooper University Hospital Camden, NJ

  • Henry Fraimow, MD
    Associate Professor of Medicine

Planning Committee
  • Beth Hurley, MPH
    Training & Consultation Specialist
  • Anita Khilall, MPH, CHES
    Training & Consultation Specialist

If you have any additional questions, please contact Beth Hurley at (973) 972-9136 or email at

If you require an accommodation because of a disability, or if you have any additional needs, please contact Anita Khilall at (973) 972-9102, or send an email to